Mostrar el registro sencillo del ítem

dc.creatorSakkas L.I.en
dc.date.accessioned2023-01-31T09:53:10Z
dc.date.available2023-01-31T09:53:10Z
dc.date.issued2019
dc.identifier10.31138/mjr.30.3.139
dc.identifier.issn24593516
dc.identifier.urihttp://hdl.handle.net/11615/78712
dc.description.abstract[No abstract available]en
dc.language.isoenen
dc.sourceMediterranean Journal of Rheumatologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85137961503&doi=10.31138%2fmjr.30.3.139&partnerID=40&md5=bf933ad09580ea1af6811a5cc7986002
dc.subjectabatacepten
dc.subjectcorticosteroid derivativeen
dc.subjectinfliximaben
dc.subjectrituximaben
dc.subjecttocilizumaben
dc.subjecttofacitiniben
dc.subjecttumor necrosis factor antibodyen
dc.subjectantisynthetase syndromeen
dc.subjectaortic arch syndromeen
dc.subjectArticleen
dc.subjectCrohn diseaseen
dc.subjectDAS28en
dc.subjectdrug efficacyen
dc.subjectGreeceen
dc.subjecthealth maintenance organizationen
dc.subjecthumanen
dc.subjectinterstitial lung diseaseen
dc.subjectischemic heart diseaseen
dc.subjectIsraelen
dc.subjectpleura effusionen
dc.subjectPneumocystis pneumoniaen
dc.subjectprescriptionen
dc.subjectpulmonary hypertensionen
dc.subjectremissionen
dc.subjectrheumatic diseaseen
dc.subjectrheumatoid arthritisen
dc.subjectrheumatologyen
dc.subjectscientific literatureen
dc.subjectsurvival rateen
dc.subjectsystemic lupus erythematosusen
dc.subjectsystemic sclerosisen
dc.subjecttreatment responseen
dc.subjectGreek Rheumatology Society and Professional Association of Rheumatologistsen
dc.titleMediterranean Journal of Rheumatology September 2019 issue highlightsen
dc.typejournalArticleen


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem